However, the inhibitory potential of racemic R-/S-verapamil and of the less cardioactive R-verapamil (“dexverapamil”) [2,3] towards Pgp is also leveraged advantageously to improve the delivery of anti-cancer drugs [4,5,6]. This evidence concerns the gene PGP and cancer.